Executives of Johnson and Johnson and Merck Pharmaceuticals joined US President Joe Biden 10th March to announce their joint venture to produce 100 million additional doses of the single-dose J&J Covid-19 vaccine. Present were Biden, Alex Grotzky of J&J and Kenneth C. Frazier of Merck.
Frazier is the chairman and CEO of Merck & Co. (known as MSD outside of North America). After joining Merck & Co. as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African American man to lead a major pharmaceutical company (part of the Fortune 500 companies). He was elected to the American Philosophical Society in 2018. (After Wikipedia)
The JV is expected to help achieve the administration's newly revised goal of producing enough doses for all US adults by end of May and vaccinating all US adults by early summer.
As the US vaccination effort winds down, production will likely continue at plants around the world for further distribution, whose details are still being debated.
AABL News Digest
☰
Categories
Recent Posts
- Regional Prototype under Study
- Uganda Equator worth a visit
- Stone of Karegyeya Worth the Side Trip
- Merck CEO Lauds Alliance for J&J Covid-19 Vaccine Manufacturing
- Understanding "Herd Immunity"
- Amanda Gorman Steals Inaugural Show
- Proctor & Gamble Sponsors "The Look"
- Kenyan factory transforms into a surgical mask assembly line
- Payroll employment falls, unemployment rises in March
- What It’s Like to Have COVID-19
- Seeking Arts Editor and Contributors
- Is your device safe from ad-hackers?
- USNIH reports progress in sickle cell disease treatment
- Experts Provide Solutions to End Discriminatory Real Estate Practices
- Security guard assault on teen characteristic of Brazilian racial history